| abstract |
The invention relates to a novel solid pharmaceutical composition for oral administration of the active ingredient amisulpride, characterized in that it comprises at least one encased amisulpride particle and at least one pharmaceutically acceptable excipient which is adapted for orodispersible administration of the composition. The novel composition can, more particularly, be provided in the form an orodispersible amisulpride tablet. |